(MedPage Today) — CHICAGO — For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban (Eliquis) was just as effective as a higher dose — and safer, the API-CAT randomized trial… Source link : https://www.medpagetoday.com/meetingcoverage/acc/114876 Author : Publish date : 2025-03-29 14:30:00 Copyright for syndicated content belongs to […]
The post Lower-Dose Extended Anticoagulation Just as Effective for VTE With Active Cancer first appeared on News Health.
Author : News Health
Publish date : 2025-03-29 14:30:00
Copyright for syndicated content belongs to the linked Source.